SMTL ID : 5aaa.1

Structure of L1198F Mutant Human Anaplastic Lymphoma Kinase in Complex with Crizotinib

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.73 Å

Oligo State

monomer

Ligands

1 x VGH: 3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-(1-piperidin-4-yl-1H-pyrazol-4-yl)pyridin-2-amine(Non-covalent)

VGH.1: 15 residues within 4Å: Chain A: L.38, V.46, A.64, L.112, E.113, F.114, M.115, A.116, G.117, G.118, R.169, N.170, L.172, G.185, D.186 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:L.38, A:L.38, A:L.172 Hydrogen bonds: A:E.113, A:M.115 Water bridges: A:D.119 Halogen bonds: A:G.185

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Shaw, A.T. et al., Resensitization to Crizotinib by the Lorlatinib Alk Resistance Mutation L1198F. N.Engl.J.Med. (2016)

Release Date

2016-06-08

Peptides

ALK TYROSINE KINASE RECEPTOR: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

ALK TYROSINE KINASE RECEPTOR

Related Entries With Identical Sequence